5,345 results on '"esophageal varices"'
Search Results
2. Development and validation of a scoring system for in‐hospital mortality following band ligation in esophageal variceal bleeding.
- Author
-
Ichita, Chikamasa, Goto, Tadahiro, Okada, Yohei, Uojima, Haruki, Iwagami, Masao, Sasaki, Akiko, and Shimizu, Sayuri
- Subjects
- *
SYSTOLIC blood pressure , *GLASGOW Coma Scale , *ESOPHAGEAL varices , *FAMILY communication , *PATIENTS' families - Abstract
Objectives: We aimed to develop and validate a simple scoring system to predict in‐hospital mortality after endoscopic variceal ligation (EVL) for esophageal variceal bleeding. Methods: Data from a 13‐year study involving 46 Japanese institutions were split into development (initial 7 years) and validation (last 6 years) cohorts. The study subjects were patients hospitalized for esophageal variceal bleeding and treated with EVL. Variable selection was performed using least absolute shrinkage and selection operator regression, targeting in‐hospital all‐cause mortality as the outcome. We developed the Hospital Outcome Prediction following Endoscopic Variceal Ligation (HOPE‐EVL) score from β coefficients of multivariate logistic regression and assessed its discrimination and calibration. Results: The study included 980 patients: 536 in the development cohort and 444 in the validation cohort. In‐hospital mortality was 13.6% and 10.1% for the respective cohorts. The scoring system used five variables: systolic blood pressure (<80 mmHg: 2 points), Glasgow Coma Scale (≤12: 1 point), total bilirubin (≥5 mg/dL: 1 point), creatinine (≥1.5 mg/dL: 1 point), and albumin (<2.8 g/dL: 1 point). The risk groups (low: 0–1, middle: 2–3, high: ≥4) in the validation cohort corresponded to observed and predicted mortality probabilities of 2.0% and 2.5%, 19.0% and 22.9%, and 57.6% and 71.9%, respectively. In this cohort, the HOPE‐EVL score demonstrated excellent discrimination ability (area under the curve [AUC] 0.890; 95% confidence interval [CI] 0.850–0.930) compared with the Model for End‐stage Liver Disease score (AUC 0.853; 95% CI 0.794–0.912) and the Child–Pugh score (AUC 0.798; 95% CI 0.727–0.869). Conclusions: The HOPE‐EVL score practically and effectively predicts in‐hospital mortality. This score could facilitate the appropriate allocation of resources and effective communication with patients and their families. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Systematic review of machine learning models in predicting the risk of bleed/grade of esophageal varices in patients with liver cirrhosis: A comprehensive methodological analysis.
- Author
-
Malik, Sheza, Tenorio, Bettina Gabrielle, Moond, Vishali, Dahiya, Dushyant Singh, Vora, Ravi, and Dbouk, Nader
- Subjects
- *
MACHINE learning , *ARTIFICIAL neural networks , *CONVOLUTIONAL neural networks , *ESOPHAGEAL varices , *CIRRHOSIS of the liver - Abstract
Esophageal varices (EV) in liver cirrhosis carry high mortality risks. Traditional endoscopy, which is costly and subjective, prompts a shift towards machine learning (ML). This review critically evaluates ML applications in predicting bleeding risks and grading EV in patients with liver cirrhosis. Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) guidelines, we conducted a systematic review of studies using ML to predict the risk of variceal bleeding and/or grade EV in liver disease patients. Data extraction and bias assessment followed the CHARMS (CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modeling Studies) checklist and PROBAST (Prediction model Risk Of Bias Assessment Tool) tool, respectively. Due to the heterogeneity of the study, a meta‐analysis was not feasible; instead, descriptive statistics summarized the findings. Twelve studies were included, highlighting the use of various ML models such as extreme gradient boosting, artificial neural networks, and convolutional neural networks. These studies demonstrated high predictive accuracy, with some models achieving area under the curve values above 99%. However, significant heterogeneity was noted in input variables, methodologies, and outcome measures. Moreover, a substantial portion of the studies exhibited unclear or high risk of bias, mainly due to insufficient participant numbers, unclear handling of missing data, and a lack of detailed reporting on endoscopic procedures. ML models show significant promise in predicting the risk of variceal bleeding and grading EV in patients with cirrhosis, potentially reducing the need for invasive procedures. Nonetheless, the current literature reveals considerable heterogeneity and methodological limitations, including high or unclear risks of bias. Future research should focus on larger, prospective trials and the standardization of ML assessment criteria to confirm these models' practical utility in clinical settings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Efficacy of endoscopic therapy combined with partial splenic embolization versus Hassab's operation for patients with liver cirrhosis with esophageal variceal bleeding and hypersplenism: a multicenter cohort study based on propensity score matching.
- Author
-
Li, Jinhou, Wei, Min, Zeng, Yunqing, He, Chao, Sun, Ming, Zhang, Jing, Zhang, Anzhong, Zhou, Tao, and Gao, Yanjing
- Subjects
- *
GASTROINTESTINAL hemorrhage treatment , *ESOPHAGEAL varices , *GASTROINTESTINAL hemorrhage , *CIRRHOSIS of the liver , *PATIENT safety , *T-test (Statistics) , *THERAPEUTIC embolization , *ENDOSCOPIC surgery , *TREATMENT effectiveness , *RETROSPECTIVE studies , *MANN Whitney U Test , *COMBINED modality therapy , *RESEARCH , *DATA analysis software , *ENDOSCOPY , *HYPERSPLENISM , *PERIOPERATIVE care - Abstract
Background: The prognosis comparison between endoscopic therapy + partial splenic embolization (PSE) and Hassab's operation is unclear in the treatment of esophageal variceal bleeding in patients with liver cirrhosis. This study aimed to compare the outcome of endoscopic therapy + PSE (EP) with a combination of splenectomy + pericardial devascularization procedure, known as Hassab's operation (SH) for esophageal variceal bleeding in patients with liver cirrhosis with hypersplenism. Methods: We enrolled 328 patients, including 125 and 203 patients who underwent EP and SH, respectively. Each group consisted of 110 patients after propensity score matching (PSM). Subsequently, we recorded and analyzed bleeding episodes and mortality in 6 months and 1, 2, and 5 years after therapies. Results: The median follow-up time in the EP and SH groups was 53 and 64 months, respectively. Bleeding incidence 6 months after therapies in the EP group was lower than that in the SH group (1.8% vs. 10.0%, P = 0.010). Additionally, complications in the perioperative period were not significantly different (0% vs. 3.6%, P = 0.008). However, the bleeding rate between the two groups was not significantly different at 1, 2, and 5 years after therapies (7.3% vs. 12.7%, P = 0.157; 10.9% vs. 16.4%, P = 0.205; 30.6% vs. 31.8%, P = 0.801), as well as mortality rate (4.5% vs 7.3%, P = 0.571). Conclusion: Compared with SH therapy, the bleeding rate 6 months after EP therapy was lower, but the long-term bleeding rate was similar. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Outcomes in Variceal Bleeding Associated With Continuous Octreotide in Patients With Delayed Endoscopy.
- Author
-
Laws, Matthew B., Wahking, Rebekah, Blackburn, Erin, Williams, Whitney, Schadler, Aric, and Fritz, Megan Kunka
- Subjects
- *
ESOPHAGEAL varices , *GASTROINTESTINAL hemorrhage , *CIRRHOSIS of the liver , *ERYTHROCYTES , *RESEARCH funding , *HEMOGLOBINS , *TREATMENT effectiveness , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *OCTREOTIDE acetate , *LONGITUDINAL method , *ODDS ratio , *ENDOSCOPIC gastrointestinal surgery , *MEDICAL records , *ACQUISITION of data , *TREATMENT delay (Medicine) , *DISEASE relapse , *CONFIDENCE intervals , *TIME , *DISEASE complications - Abstract
Background: Variceal hemorrhage treatment includes endoscopy within 12 hours of admission and octreotide therapy for 2-5 days post-endoscopy. Duration of pre-endoscopy octreotide can be prolonged when intervention is delayed. Objective: This study aimed to evaluate the impact of extended pre-endoscopy octreotide on rebleeding after endoscopy when comparing short vs long durations of post-endoscopy octreotide. Methods: This was a single center, retrospective cohort evaluating adult cirrhotic patients with esophageal variceal hemorrhage admitted between July 1, 2017 and June 30, 2020. Study groups included patients receiving octreotide ≥12 hours prior to endoscopy followed by ≤ 48 (short course) or >48 hours (standard course) after endoscopy. The primary outcome was post-endoscopy rebleeding, defined as hemoglobin decrease of ≥2 g/dL from baseline or the requirement of ≥1 unit of packed red blood cells. Results: Of the 169 patients included, 88 patients received short course octreotide after endoscopy, and 81 patients received standard course octreotide after endoscopy. Twenty-nine (33%) patients in the short course group and 43 (53.1%) in the standard course group experienced the primary endpoint (OR 2.3, 95% CI 1.24 - 4.29; P =.008). Conclusion: Extended pre-endoscopy octreotide may be beneficial in preventing rebleeding when intervention is delayed. Further studies are needed to determine the necessary octreotide duration in delayed endoscopy and varying bleeding risk. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Nonalcoholic Fatty Liver Disease and Ethnicity: Lessons Learned from the Arab Population in Israel.
- Author
-
Abu-Freha, Naim, Eraki, lior, Weissmann, Sarah, Cohen, Bracha, Gordon, Michal, Kaf, Heba Abu, Etzion, Ohad, Tailakh, Muhammad Abu, and Delgado, Jorge-Shmuel
- Subjects
- *
NON-alcoholic fatty liver disease , *JEWS , *ESOPHAGEAL varices , *PERITONITIS , *EVALUATION of medical care , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *MANN Whitney U Test , *CHI-squared test , *ODDS ratio , *ARABS , *MEDICAL records , *ACQUISITION of data , *COMPARATIVE studies , *DATA analysis software , *COMORBIDITY , *DIABETES , *OBESITY , *LIVER transplantation , *PROPORTIONAL hazards models , *REGRESSION analysis - Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease. We aimed to investigate the potential similarities and differences regarding the disease among Arabs and Jews. Retrospective study included all patients older than 18 years with NAFLD diagnosis according to ICD-10 codes. Data regarding demographics, comorbidities, and outcomes were retrieved using the MdClone platform from "Clalit" in Israel. Data concerning 34,090 Arab patients and 173,500 Jewish patients with NAFLD were included. Arab patients were significantly younger at diagnosis (35.0 ± 13 years vs. 43.6 ± 15 years, p < 0.001) and had higher rates of obesity and diabetes mellitus (69.5% vs. 56.5% and 27.0% vs. 22.7%, p < 0.001, respectively). Arab patients had higher rates of cirrhosis and portal hypertension-related complications (2.5% vs. 2.0%, p < 0.001), esophageal varices (0.9% vs. 0.5%, p < 0.001), spontaneous bacterial peritonitis (0.3% vs. 0.1%, p < 0.001), and hepatorenal syndrome (0.3% vs. 0.1%, p < 0.001). There was no significant difference in the prevalence of hepatocellular carcinoma between study groups (0.4% vs. 0.5%, p = 0.156). Liver transplantation was performed in 0.2% of Arab NAFLD patients compared to 0.07% of Jewish NAFLD patients (p < 0.001). Lower rates of all-cause mortality were found among the Arab NAFLD patients versus Jewish NAFLD patients (7.7% versus 11.5%, p < 0.001). According to the Cox regression model, Arab ethnicity is a risk factor for death with OR of 1.36. Significant differences regarding comorbidities, complications, liver transplantations rates, and all-cause mortality were found among NAFLD patients of different ethnicities, hence specific population need specific consideration in prevention, early diagnosis and follow up. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Review article: Oesophageal disorders in chronic liver disease.
- Author
-
Idalsoaga, Francisco, Díaz, Luis Antonio, Ayares, Gustavo, Cabrera, Daniel, Chahuan, Javier, Monrroy, Hugo, Halawi, Houssam, Arrese, Marco, and Arab, Juan Pablo
- Subjects
- *
BARRETT'S esophagus , *ESOPHAGEAL varices , *LIVER diseases , *PROTON pump inhibitors , *ESOPHAGEAL cancer - Abstract
Summary: Background: Oesophageal disorders and chronic liver disease are common worldwide and significantly impact quality of life. The intricate link between these conditions, including how oesophageal disorders like GERD, Barrett's oesophagus and oesophageal cancer affect and are affected by chronic liver disease, remains poorly understood. Aims: To review the relationship between oesophageal disorders and chronic liver disease, evaluating epidemiology, pathophysiology and therapeutic factors. Methods: We reviewed the literature on the relationship between oesophageal disorders and chronic liver disease, including cirrhosis, using the PubMed database Results: Oesophageal disorders such as gastroesophageal reflux disease, Barrett's oesophagus, oesophageal cancer, oesophageal motor disorders and oesophageal candidiasis are prevalent among individuals with cirrhosis, exacerbating the burden of liver disease. These diseases have a multifaceted symptomatology and pathogenic basis, posing a significant challenge in cirrhotic patients that necessitates careful diagnosis and management. Additionally, therapies frequently used for these diseases, such as proton pump inhibitors, require careful consideration in cirrhotic patients due to potential adverse effects and altered pharmacokinetics. Managing oesophageal disorders in cirrhotic patients requires a cautious approach due to possible interactions with medications and the risk of adverse effects. Furthermore, symptoms associated with these conditions are often exacerbated by common interventions in patients with cirrhosis, such as band ligation for oesophageal varices. Conclusions: Oesophageal disorders are common in cirrhosis and increase the disease burden. These conditions require careful management due to complex symptoms and treatment risks. Proton pump inhibitors and other therapies must be used cautiously, as cirrhosis interventions can worsen symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Causal effects of genetically determined metabolites and metabolite ratios on esophageal diseases: a two-sample Mendelian randomization study.
- Author
-
Yang, Hanlei, Wang, Yulan, Zhao, Yuewei, Cao, Leiqun, Chen, Changqiang, and Yu, Wenjun
- Subjects
- *
ESOPHAGEAL varices , *ESOPHAGUS diseases , *ESOPHAGEAL perforation , *DICARBOXYLIC acids , *ESOPHAGEAL tumors - Abstract
Background: Esophageal diseases (ED) are a kind of common diseases of upper digestive tract. Previous studies have proved that metabolic disorders are closely related to the occurrence and development of ED. However, there is a lack of evidence for causal relationships between metabolites and ED, as well as between metabolite ratios representing enzyme activities and ED. Herein, we explored the causality of genetically determined metabolites (GDMs) on ED through Mendelian Randomization (MR) study. Methods: Two-sample Mendelian randomization analysis was used to assess the causal effects of genetically determined metabolites and metabolite ratios on ED. A genome-wide association analysis (GWAS) encompassing 850 individual metabolites along with 309 metabolite ratios served as the exposures. Meanwhile, the outcomes were defined by 10 types of ED phenotypes, including Congenital Malformations of Esophagus (CME), Esophageal Varices (EV), Esophageal Obstructions (EO), Esophageal Ulcers (EU), Esophageal Perforations (EP), Gastroesophageal Reflux Disease (GERD), Esophagitis, Barrett's Esophagus (BE), Benign Esophageal Tumors (BETs), and Malignant Esophageal Neoplasms (MENs). The standard inverse variance weighted (IVW) method was applied to estimate the causal relationship between exposure and outcome. Sensitivity analyses were carried out using multiple methods, including MR-Egger, Weighted Median, MR-PRESSO, Cochran's Q test, and leave-one-out analysis. P < 0.05 was conventionally considered statistically significant. After applying the Bonferroni correction for multiple testing, a threshold of P < 4.3E-05 (0.05/1159) was regarded as indicative of a statistically significant causal relationship. Furthermore, metabolic pathway analysis was performed using the web-based MetaboAnalyst 6.0 software. Results: The findings revealed that initially, a total of 869 candidate causal association pairs ( P ivw < 0.05) were identified, involving 442 metabolites, 145 metabolite ratios and 10 types of ED. However, upon applying the Bonferroni correction for multiple testing, only 36 pairs remained significant, involving 28 metabolites (predominantly lipids and amino acids), 5 metabolite ratios and 6 types of ED. Sensitivity analyses and reverse MR were performed for these 36 causal association pairs, where the results showed that the pair of EV and 1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) did not withstand the sensitivity tests, and Hexadecenedioate (C16:1-DC) was found to have a reverse causality with GERD. The final 34 robust causal pairs included 26 metabolites, 5 metabolite ratios and 5 types of ED. The involved 26 metabolites predominantly consisted of methylated nucleotides, glycine derivatives, sex hormones, phospholipids, bile acids, fatty acid dicarboxylic acid derivatives, and N-acetylated amino acids. Furthermore, through metabolic pathway analysis, we uncovered 8 significant pathways that played pivotal roles in five types of ED conditions. Conclusions: This study integrated genomics with metabolomics to assess causal relationships between ED and both metabolites and metabolite ratios, uncovering several key metabolic features in ED pathogenesis. These findings have potential as novel biomarkers for ED and provide insights into the disease's etiology and progression. However, further clinical and experimental validations are necessary [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Evaluation of Noninvasive Tools for Predicting Esophageal Varices in Patients With Cirrhosis at Tygerberg Hospital, Cape Town.
- Author
-
Kwape, Lawrence, Gabriel, Shiraaz, Abdelsalem, Ahmad, Rose, Penelope, Bathobakae, Lefika, Peterson, Dale, Moodley, Desiree, Parker, Mohammed, Moolla, Saadiq, Parker, Arifa, Siamisang, Keatlaretse, Van Rensburg, Christoffel, Fredericks, Ernst, and Uhlmann, Dirk
- Subjects
- *
AUTOIMMUNE hepatitis , *ESOPHAGEAL varices , *HEPATITIS B virus , *PORTAL hypertension , *PORTAL vein , *ACOUSTIC radiation force impulse imaging - Abstract
Background: In patients with cirrhosis, esophageal variceal hemorrhage (EVH) is a devastating consequence of portal hypertension (PH). Upper endoscopy is considered the gold standard for the detection and diagnosis of esophageal varices (EVs), despite being invasive and costly. This study was aimed at identifying and evaluating the diagnostic accuracy of noninvasive tools in predicting EVs in patients with compensated cirrhosis. Methods: This cross‐sectional study included 50 patients with compensated cirrhosis at the Tygerberg Hospital Gastroenterology Clinic in Cape Town between November 2022 and May 2023. We collected clinical, anthropometric, and laboratory data from patients' physical and electronic charts. All patients underwent an abdominal ultrasound, vibration‐controlled transient elastography (VCTE) to assess liver and splenic stiffness, and upper endoscopy. In this comparative study, we evaluated the diagnostic accuracy of different noninvasive tools in detecting EVs in patients with compensated cirrhosis. Results: Of the 50 patients included in the study, 30 (60%) were female and 20 (40%) were male. The patients' age ranged from 18 to 83, with a mean age of 46.6 years. Cirrhosis was mainly due to alcohol use (n = 11, 22%), hepatitis B virus (HBV) infection (n = 11, 22%), and autoimmune hepatitis (n = 10, 20%). The patients included in the study were divided into two subgroups: with (n = 34, 68%) or without (n = 16, 32%) EVs. Statistically significant differences were detected between groups in platelet count (PC), liver stiffness measurement (LSM), spleen stiffness measurement (SSM), portal vein diameter (PVD), bipolar spleen diameter (SBD), aspartate aminotransferase‐to‐platelet ratio index (APRI), fibrosis‐4 index (FIB‐4), platelet/bipolar spleen diameter ratio (PSR), liver stiffness‐spleen size‐platelet ratio (LSPS), liver stiffness‐spleen stiffness‐platelet ratio score (LS3PS), and spleen stiffness‐spleen size‐platelet ratio score (SSPS) (p < 0.001). The highest diagnostic precision was observed with SSM (96%), SSPS (96%), LS3PS (94%), LSPS (94%), PSR (94%), and PC (92%). SBD (88%), LSM (86%), APRI (82%), and FIB‐4 (82%) had the lowest diagnostic accuracy. Conclusion: SSM and SSPS have the highest diagnostic accuracy for predicting the presence of EVs in patients with compensated cirrhosis. LSPS, LS3PS, and PSR come second at 94%. We recommend SSM and SSPS in institutions with transient elastography equipped with the software necessary to measure splenic stiffness. We introduce and propose LS3PS as a novel composite score for predicting the presence of EVs in patients with compensated cirrhosis. Large‐sample‐size studies are needed to validate these prediction scores and to allow direct comparison with Baveno VII. These prediction tools can help clinicians avoid unnecessary endoscopic procedures in patients with compensated cirrhosis, especially in developing countries with limited resources such as South Africa. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Applications of Artificial Intelligence-Based Systems in the Management of Esophageal Varices.
- Author
-
Brata, Vlad Dumitru, Incze, Victor, Ismaiel, Abdulrahman, Turtoi, Daria Claudia, Grad, Simona, Popovici, Raluca, Duse, Traian Adrian, Surdea-Blaga, Teodora, Padureanu, Alexandru Marius, David, Liliana, Dita, Miruna Oana, Baldea, Corina Alexandrina, and Popa, Stefan Lucian
- Subjects
- *
ARTIFICIAL intelligence , *PORTAL hypertension , *MACHINE learning , *DEEP learning , *COMPUTED tomography - Abstract
Background: Esophageal varices, dilated submucosal veins in the lower esophagus, are commonly associated with portal hypertension, particularly due to liver cirrhosis. The high morbidity and mortality linked to variceal hemorrhage underscore the need for accurate diagnosis and effective management. The traditional method of assessing esophageal varices is esophagogastroduodenoscopy (EGD), which, despite its diagnostic and therapeutic capabilities, presents limitations such as interobserver variability and invasiveness. This review aims to explore the role of artificial intelligence (AI) in enhancing the management of esophageal varices, focusing on its applications in diagnosis, risk stratification, and treatment optimization. Methods: This systematic review focuses on the capabilities of AI algorithms to analyze clinical scores, laboratory data, endoscopic images, and imaging modalities like CT scans. Results: AI-based systems, particularly machine learning (ML) and deep learning (DL) algorithms, have demonstrated the ability to improve risk stratification and diagnosis of esophageal varices, analyzing vast amounts of data, identifying patterns, and providing individualized recommendations. However, despite these advancements, clinical scores based on laboratory data still show low specificity for esophageal varices, often requiring confirmatory endoscopic or imaging studies. Conclusions: AI integration in managing esophageal varices offers significant potential for advancing diagnosis, risk assessment, and treatment strategies. While promising, AI systems should complement rather than replace traditional methods, ensuring comprehensive patient evaluation. Further research is needed to refine these technologies and validate their efficacy in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Early Onset Felty Syndrome in Rheumatoid Arthritis: A Case Report.
- Author
-
KUMAR, ABHISHEK, HARIKRISHNAN, P., MANRAI, MANISH, and KUMAR, ABHINAV
- Subjects
- *
ESOPHAGEAL varices , *HLA histocompatibility antigens , *PORTAL hypertension , *RHEUMATOID arthritis , *AUTOIMMUNE diseases - Abstract
Felty syndrome is a rare and serious complication of Rheumatoid Arthritis (RA), characterised by a triad of RA, splenomegaly (enlarged spleen), and neutropenia (low neutrophil count). RA, a systemic autoimmune inflammatory disease marked by synovitis, commonly occurs in the fifth or sixth decade of life and often affects patients with a history of RA exceeding ten years. It is more prevalent in the Caucasian population due to the underexpression of the Human Leukocyte Antigen (HLA)-DR4 gene in African Americans. Felty syndrome requires the presence of neutropenia, defined as an Absolute Neutrophil Count (ANC) below 2000 cells/mm³, alongside splenomegaly and long-standing RA. Hereby, the authors present a case report of a 44-year-old female with a three-year history of RA, who presented with ascites for nine months and was found to have portal hypertension. Her diagnosis of Felty syndrome was confirmed based on the triad of RA, neutropenia, and splenomegaly, highlighting the importance of early recognition and management to prevent severe complications such as infections and systemic issues like portal hypertension. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Long-term surveillance of gastric varices after cyanoacrylate injection in patients with non-cirrhotic portal hypertension: is it worth the effort?
- Author
-
Morell, Bernhard, Murray, Fritz Ruprecht, Gubler, Christoph, Schlag, Christoph, Kremer, Andreas E., and Deibel, Ansgar
- Subjects
- *
PATIENT portals , *GASTRIC varices , *HEPATIC fibrosis , *ENDOSCOPIC ultrasonography , *ESOPHAGEAL varices , *GASTROINTESTINAL hemorrhage - Abstract
This document provides a summary of a study on the long-term surveillance of gastric varices (GV) in patients with non-cirrhotic portal hypertension (NCPH). The study found that repeat secondary prophylactic interventions for GV rarely occur beyond four years, and rebleeding can still occur despite endoscopic ultrasound (EUS) surveillance and treatment. However, late rebleeding may have a good prognosis. The study suggests that larger prospective cohorts would be valuable to confirm these findings. The document also includes supplementary materials related to the article and information about conflicts of interest and funding. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
13. Burden of Portal Hypertension Complications Is Greater in Liver Transplant Wait-Listed Registrants with End-Stage Liver Disease and Type 2 Diabetes.
- Author
-
Yakubu, Idris, Flynn, Sean, Khan, Hiba, Nguyen, Madison, Razzaq, Rehan, Patel, Vaishali, Kumaran, Vinay, Sharma, Amit, and Siddiqui, Mohammad Shadab
- Subjects
- *
TYPE 2 diabetes , *RENAL replacement therapy , *ESOPHAGEAL varices , *HEPATIC encephalopathy , *PORTAL hypertension - Abstract
Background and Aims: Impact of type 2 diabetes mellitus (T2DM) in patients with end-stage liver disease (ESLD) awaiting liver transplantation (LT) remains poorly defined. The objective of the present study is to evaluate the relationship between T2DM and clinical outcomes among patients with LT waitlist registrants. We hypothesize that the presence of T2DM will be associated with worse clinical outcomes. Methods: 593 patients adult (age 18 years or older) who were registered for LT between 1/2010 and 1/2017 were included in this retrospective analysis. The impact of T2DM on liver-associated clinical events (LACE), survival, hospitalizations, need for renal replacement therapy, and likelihood of receiving LT were evaluated over a 12-month period. LACE was defined as variceal hemorrhage, hepatic encephalopathy, and ascites. Kaplan–Meier and Cox regression analysis were used to determine the association between T2DM and clinical outcomes. Results: The baseline prevalence of T2DM was 32% (n = 191) and patients with T2DM were more likely to have esophageal varices (61% vs. 47%, p = 0.002) and history of variceal hemorrhage (23% vs. 16%, p = 0.03). The presence of T2DM was associated with increased risk of incident ascites (HR 1.91, 95% CI 1.11, 3.28, p = 0.019). Patients with T2DM were more likely to require hospitalizations (56% vs. 49%, p = 0.06), hospitalized with portal hypertension-related complications (22% vs. 14%; p = 0.026), and require renal replacement therapy during their hospitalization. Patients with T2DM were less likely to receive a LT (37% vs. 45%; p = 0.03). Regarding MELD labs, patients with T2DM had significantly lower bilirubin at each follow-up; however, no differences in INR and creatinine were noted. Conclusion: Patients with T2DM are at increased risk of clinical outcomes. This risk is not captured in MELD score, which may potentially negatively affect their likelihood of receiving LT. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Comparison of gastrointestinal bleeding in patients with and without liver cirrhosis.
- Author
-
Daðadóttir, Sara Margret, Ingason, Arnar Bragi, Hreinsson, Johann Pall, and Björnsson, Einar Stefan
- Subjects
- *
ESOPHAGEAL varices , *GASTROINTESTINAL hemorrhage , *STOMACH ulcers , *CIRRHOSIS of the liver , *PEPTIC ulcer , *DUODENAL ulcers , *HEMORRHOIDS - Abstract
Objectives: Upper gastrointestinal bleeding (GIB) in patients has been well-characterized in liver cirrhosis but studies on lower GIB are limited. The clinical characteristics, management and outcomes in patients with and without liver cirrhosis was compared to determine the overall features of GIB in patients with liver cirrhosis compared with non-cirrhotics. Methods: A retrospective study on cirrhotics hospitalized for GIB 2010–2021, matched with control group of non-cirrhotics (1:4) for upper vs. lower GIB. Patients with overt bleeding leading to hospitalization were included. Results: Overall, 396 patients had cirrhosis, 267 (67%) men, median age 62, alcoholic etiology 177/396 (45%), median MELD 12 (range 6–32). Overall 102 cirrhotics had GIB, matched with 391 non-cirrhotics. Overall 87 (85%) cirrhotic patients had upper and 15% lower GIB. Compared to non-cirrhotics, the cause of GIB was more commonly acute variceal bleeding (AVB) (42% vs. 1%), hemorrhoids 40% vs. 6% (p = 0.002), less commonly gastric ulcer 13% vs. 31% (p < 0.001), duodenal ulcer 9% vs. 29% (p < 0.001), 5% of cirrhotics used NSAIDs vs. 26% of controls (p < 0.001). Rebleeding occurred in 14% of cirrhotics vs. 3% in controls (p < 0.001). Only one cirrhotic patient (1%) died from GIB vs. 0.8% of controls within 45 days. Overall mortality 45 days after hospitalization was 10% in cirrhotics vs. 5% in controls (p < 0.001) Conclusions: Bleeding from gastric and duodenal ulcers were less common in cirrhotics than in controls. Bleeding from hemorrhoids was more common in cirrhotics. Mortality due to GIB was low in both groups but overall mortality was significantly higher in cirrhotics. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. The learning curve of laparoscopic splenectomy and esophagogastric devascularization for portal hypertension with 10-year follow-up.
- Author
-
Wang, Dong, Chen, Xiao, Lv, Ling, Yang, Tao, Huang, Bo, Cao, Yanlong, Zhang, Yong, Lu, Jianguo, and Yin, Jikai
- Subjects
- *
ESOPHAGEAL varices , *T-test (Statistics) , *RESEARCH funding , *PORTAL hypertension , *LAPAROSCOPIC surgery , *COMPUTED tomography , *FISHER exact test , *RETROSPECTIVE studies , *SURGICAL blood loss , *TREATMENT effectiveness , *MANN Whitney U Test , *CHI-squared test , *DESCRIPTIVE statistics , *SURGICAL complications , *LOG-rank test , *SPLENECTOMY , *DATA analysis software , *OVERALL survival , *ABDOMINAL radiography , *PATIENT aftercare - Abstract
Introduction and objectives: Laparoscopic splenectomy and esophagogastric devascularization (LSED) are minimally invasive, effective, and safe in treating esophageal-fundic variceal bleeding with portal hypertension (PHT). The study aimed to assess the learning curve of LSED by cumulative summation (CUSUM) analysis. The 10-year follow-up data for LSED and open surgery were also examined. Patients and methods: Five hundred and ninety-four patients were retrospectively analyzed. Operation time, intraoperative blood loss, open operation conversion, and postoperative complications were selected as the evaluation indicators of surgical ability. The learning curve of LESD was assessed by the CUSUM approach. Patient features, perioperative indices, and 10-year follow-up data were examined. Results: Totally 236 patients underwent open surgery, and 358 underwent LSED. Patient characteristics were similar between groups. The LSED patients experienced less intraoperative blood loss, fewer complications, and faster recovery compared to the open surgery cohort. The learning curve of LESD was maximal for a case number of 50. Preoperative general characteristics were comparable for both stages. But the skilled stage had decreased operation time, reduced blood loss, less postoperative complications, and better recovery compared to the learning stage. The LSED group had higher recurrent hemorrhage-free survival rate and increased overall survival in comparison with cases administered open surgery in the 10-year follow-up. Free-liver cancer rates were similar between two groups. Conclusions: About 50 cases are needed to master the LSED procedure. Compared to open surgery, LSED is a safer, feasible, and safe procedure for PHT patients, correlating with decreased rebleeding rate and better overall survival. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Magnetic resonance elastography (MRE) outperforms acoustic force radiation impulse (ARFI) in predicting oesophageal varices in obese NAFLD cirrhosis.
- Author
-
Roy, Akash, Verma, Nipun, Jajodia, Surabhi, Goenka, Usha, Tiwari, Awanish, Sonthalia, Nikhil, and Goenka, Mahesh
- Subjects
- *
NON-alcoholic fatty liver disease , *ESOPHAGEAL varices , *RECEIVER operating characteristic curves , *INDEPENDENT variables , *ACOUSTIC radiation - Abstract
Purpose: Liver stiffness measurement (LSM) by transient elastography has been shown to underperform in high-risk varices (HRVs) prediction in obese non-alcoholic fatty liver disease (NAFLD) compensated cirrhosis (CC). LSM by magnetic resonance elastography (MRE) and acoustic force radiation impulse (ARFI) has been shown to be useful in prediction of oesophageal varices (EVs), but has limited evidence in obese NAFLD-CC. Methods: Obese patients with NAFLD-CC who underwent MRE and ARFI for LSM and endoscopy for screening of varices were enrolled. Performance of MRE and ARFI for predicting EVs or HRVs was evaluated using area under receiver operating characteristics (AUROC) curves and regression analyses were performed for predictor variables. Results: One hundred eight patients [mean age 54.7 ± 9.6 years, median BMI, 28.5 (26.4–30.0) kg/m2. 72.2% diabetics, 45.4% hypertensive] were enrolled. Fifty-two (48.1%) had no varices, while 29 (26.8%) and 27 (25%) had low-risk varices (LRVs) and HRVs, respectively. MRE-LSM was higher in patients with LRVs (p = 0.01) or HRVs (p = 0.001) against those without varices. ARFI-LSM did not differ significantly between those without and with LRVs or HRVs (p > 0.05 for all). There was a low correlation between ARFI-LSM and MRE-LSM in the overall cohort (r = 0.19). Only platelet count (PC) [0.98 (0.97–0.99)] and MRE-LSM [1.8 (1.26–2.79)] were predictors of HRVs. At a cut-off of 4.75, MRE showed a sensitivity of 96.3%. Model combining MRE-LSM with PC had a diagnostic AUROC of 0.77 and 0.76 for EVs and HRVs. Conclusion: In obese NAFLD-CC, MRE-LSM is significantly higher in patients with varices. MRE combined with PC predicts EVs and HRVs with better accuracy than ARFI. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. 常染色体隐性遗传性多囊肾1例.
- Author
-
许欣雨, 周青梅, 田云粉, 赵琼, 潘菡, 陈芊廷, 罗玉妹, 郭征征, 李天鹤, and 杨景晖
- Subjects
AUTOSOMAL recessive polycystic kidney ,INTRAHEPATIC bile ducts ,GENETIC testing ,GASTRIC varices ,ESOPHAGEAL varices ,GASTROINTESTINAL hemorrhage - Abstract
Copyright of Chinese Journal of Contemporary Pediatrics is the property of Xiangya Medical Periodical Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
18. Useful Predictor for Exacerbation of Esophagogastric Varices after Hepatitis C Virus Eradication by Direct-Acting Antivirals.
- Author
-
Nagaoki, Yuko, Yamaoka, Kenji, Fujii, Yasutoshi, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Murakami, Eisuke, Kawaoka, Tomokazu, Miki, Daiki, Aikata, Hiroshi, Hayes, C. Nelson, Tsuge, Masataka, and Oka, Shiro
- Subjects
LIVER histology ,DISEASE exacerbation ,RISK assessment ,ESOPHAGEAL varices ,RECEIVER operating characteristic curves ,PLATELET count ,CELIAC artery ,CIRRHOSIS of the liver ,BILE acids ,COMPUTED tomography ,DESCRIPTIVE statistics ,MANN Whitney U Test ,MULTIVARIATE analysis ,SEVERITY of illness index ,ENDOSCOPIC surgery ,ANTIVIRAL agents ,KAPLAN-Meier estimator ,LOG-rank test ,STATISTICS ,HEPATITIS C ,DATA analysis software ,PROPORTIONAL hazards models ,ENDOSCOPY ,BLOOD - Abstract
To clarify the risk factors for the aggravation of esophagogastric varices (EGVs) after hepatitis C virus (HCV) eradication with direct-acting antiviral (DAA) therapy, we enrolled 167 consecutive patients with HCV-related compensated cirrhosis who achieved a sustained virological response (SVR) after DAA therapy. During a median of 69 months, EGVs were aggravated in 42 (25%) patients despite SVR. The cumulative 1-, 3-, 5-, and 10-year aggravated EGV rates were 7%, 23%, 25%, and 27%, respectively. Multivariate analysis identified a platelet count < 11.0 × 10
4 /μL, LSM ≥ 18.0 kPa, total bile acid ≥ 33.0 μmol/L, and a diameter of left gastric vein (LGV) ≥ 5.0 mm at HCV eradication as independent risk factors for EGV aggravation post-SVR. In groups that met all of these risks, the cumulative EGV aggravation rates at 1, 3, and 5 years were 27%, 87%, and 91%, respectively. However, none of the patients who had only one or none of the risk factors experienced EGV aggravation. Platelet count, LSM, total bile acid, and diameter of LGV at HCV eradication were associated with aggravated EGV post-SVR. EGVs tend to worsen as two or more of these risk factors increase. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
19. Diagnostic yield from symptomatic gastroscopy in the UK: British Society of Gastroenterology analysis using data from the National Endoscopy Database.
- Author
-
Beaton, David Robert, Sharp, Linda, Lu, Liya, Trudgill, Nigel J., Thoufeeq, Mo, Nicholson, Brian D., Rogers, Peter, Docherty, James, Jenkins, Anna, Morris, Allan John, Rösch, Thomas, and Rutter, Matthew D.
- Subjects
MEDICAL personnel ,BARRETT'S esophagus ,PATIENTS ,ESOPHAGEAL varices ,COVID-19 pandemic ,DUODENAL ulcers ,GASTROINTESTINAL hemorrhage - Published
- 2024
- Full Text
- View/download PDF
20. Coil- and Plug-Assisted Transvenous Retrograde Obliteration (CARTO/PARTO) in the Treatment of Gastric Varices: A European Single Centre Experience.
- Author
-
Pelle, Giuseppe, Andresciani, Flavio, Messina, Massimo, Nardelli, Silvia, Ridola, Lorenzo, Notarianni, Ermanno, Saltarelli, Adelchi, Gioia, Stefania, Tanzilli, Alessandro, and Ambrogi, Cesare
- Subjects
ESOPHAGEAL varices ,PATIENT safety ,PORTAL hypertension ,THERAPEUTIC embolization ,SURGICAL anastomosis ,COMPUTED tomography ,TREATMENT effectiveness ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,CASE studies ,DISEASE complications - Abstract
In Europe, transjugular intrahepatic portosystemic shunt (TIPS) is considered the primary treatment for gastric varix (GV) bleeding to reduce portal hypertension. However, in Asian countries, balloon-occluded retrograde transvenous obliteration (BRTO) and its variants plug/coil assisted transvenous retrograde obliteration (PARTO/CARTO) are the preferred approaches. The purpose of this study is to report a European single-center experience in the use of PARTO/CARTO techniques for the treatment of GVs in patients with portal hypertension, focusing on the effectiveness and safety of the procedure. All the procedures involving the PARTO/CARTO techniques performed from 2019 to 2023 were retrospectively evaluated. Technical success was defined as the complete obliteration of both the GVs and the gastro-renal (GR) shunt on review of the Computed Tomography (CT) scan performed 3 days after the procedure. The obliteration rate was also evaluated through performing CT scans 1 and 12 months after the procedure, and through endoscopic follow-up at 3 and 6 months. Additionally, major and minor complications were reported. The study involved seven patients, with a technical success of 100%. During follow-up, there were no episodes of variceal rebleeding or upper gastrointestinal bleeding. Two patients developed ascites, which resolved with medical therapy. One patient exhibited focal portal thrombosis, which was successfully treated with heparin. PARTO/CARTO techniques demonstrated high technical and clinical success rates, offering advantages over traditional BRTO. The use of coils and plugs simplifies the procedure, eliminates sclerosing agents, and prevents complications associated with balloon guiding catheters. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Predictive factors of portal hypertensive enteropathy exacerbations based on long-term outcomes.
- Author
-
Matsubara, Yuka, Tsuboi, Akiyoshi, Hirata, Issei, Sumioka, Akihiko, Takasago, Takeshi, Tanaka, Hidenori, Yamashita, Ken, Hiyama, Yuichi, Takigawa, Hidehiko, Murakami, Eisuke, Tsuge, Masataka, Urabe, Yuji, and Oka, Shiro
- Subjects
- *
ESOPHAGEAL varices , *PORTAL hypertension , *PATIENT portals , *GASTROINTESTINAL hemorrhage , *HYPERTENSION - Abstract
Background: Portal hypertensive enteropathy (PHE) is a small-bowel lesion observed in patients with portal hypertension. The clinical significance of endoscopic findings in PHE remains unclear. We aimed to clarify the clinical significance and predictive factors of capsule endoscopic findings in patients with PHE based on long-term outcomes. Methods: This retrospective study enrolled 55 patients with PHE (33 males and 22 females; median age, 64 years; range, 23–87) followed for > 3 years using capsule endoscopy (CE) between February 2009 and May 2023. We evaluated the clinical factors affecting PHE exacerbations and the effects of PHE exacerbations on gastrointestinal bleeding by comparing exacerbated and unchanged PHE groups. Results: Overall, 3 (5%) patients showed improvement, 33 (60%) remained unchanged, and 19 (35%) showed exacerbation on follow-up CE. In the exacerbated group, the rates of worsened fibrosis-4 index, exacerbated esophageal varices, and exacerbated portal hypertensive gastropathy were significantly higher than those in the unchanged group (21%, 32%, and 42% vs. 3%, 6%, and 12%, respectively; P < 0.05), and the rate of splenectomy was significantly lower in the exacerbated group than in the unchanged group (5% vs. 39%, respectively; P < 0.01). In multivariate analysis, exacerbation of esophageal varices and absence of splenectomy were significantly associated with PHE exacerbation. The rate of gastrointestinal bleeding after follow-up CE was significantly high in the exacerbated group (log-rank, P = 0.037). Conclusions: Exacerbation of esophageal varices and splenectomy were significantly associated with exacerbation of PHE. Exacerbated PHE requires specific attention to prevent gastrointestinal bleeding. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Clinical characteristics and management of patient with portal hypertension at tertial level hospital in Tanzania.
- Author
-
Itule, Paul William, Mwanga, Ally, Khamisi, Ramadhani Hassani, Byomuganyizi, Moses, Lutege, William, and Kagaruki, Tryphone Buchard
- Subjects
PATIENT portals ,CIRRHOSIS of the liver ,ALCOHOLISM ,HYPERTENSION ,LIVER transplantation - Abstract
Background: Portal hypertension is a common diagnosis in Sub-Saharan African countries, with the majority of patients presenting late. This study aimed to understand Clinical characteristics, aetiology, the treatment offered in our setting, and factors associated with portal hypertension at a tertiary-level hospital, in Tanzania. Methodology: A prospective cross-sectional observational single hospital-based study was conducted at MNH, from May 2021 to April 2022. A minimum of 152 subjects were required with an error of less than 5% and a study power of 80% at a 95% confidence interval. A structured questionnaire was used to collect data. Ethical clearance was obtained from the MUHAS/MNH IRB. Results: A total of 154 eligible participants consented and participated in this study. The mean age of participants was 42 ± 15.8 years (range 2–87). Most of the study participants were males 64.9% with a male-to-female (M: F) ratio of 1.8:1. Vomiting blood was the common symptom among the study participants 51.3%. Schistosomiasis 53.9% and viral infection 26.6% were the common etiologies followed by alcohol abuse 7.8%. Most were medically treated at 89.61% followed by radiological treatment at 8.44% while only 1.95% of patients received surgical treatment. There was a significant association between the grade of oesophagal varices and bleeding consequences (p-value < 0.01). Conclusion: The majority of patients were medically treated while patients who require surgical care are unable to assess it. We recommend the establishment of a transplant services program to counteract the unmet need and more retrospective research toward policy establishment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. EUS-Guided Vascular Interventions: Recent Advances.
- Author
-
Singh, Sahib, Chandan, Saurabh, Inamdar, Sumant, Kadkhodayan, Kambiz S., Dhar, Jahnvi, Samanta, Jayanta, and Facciorusso, Antonio
- Subjects
- *
GASTRIC varices , *ESOPHAGEAL varices , *SPLENIC artery , *ENDOSCOPIC ultrasonography , *NEW trials - Abstract
Endoscopic ultrasound (EUS)-guided vascular interventions were first reported in 2000 in a study that evaluated the utility of EUS in sclerotherapy of esophageal varices. Currently, gastric variceal therapy and portosystemic pressure gradient (PPG) measurements are the most widely utilized applications. Ectopic variceal obliteration, splenic artery embolization, aneurysm/pseudoaneurysm treatment, portal venous sampling, and portosystemic shunt creation using EUS are some of the other emerging interventions. Since the release of the American Gastroenterological Association (AGA)'s commentary in 2023, which primarily endorses EUS-guided gastric variceal therapy and EUS-PPG measurement, several new studies have been published supporting the use of EUS for various vascular conditions. In this review, we present the recent advances in this field, critically appraising new studies and trials. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. The diagnostic accuracy of triphasic abdominal CT in detecting esophageal varices.
- Author
-
Lukoo, Suzana, Musa, Balowa, Salingwa, Lilian, Mpemba, Gerard, and Jusabani, Ahmed
- Subjects
ESOPHAGEAL varices ,RESOURCE-limited settings ,COMPUTED tomography ,VENOUS thrombosis ,GASTROINTESTINAL hemorrhage - Abstract
Background: In Tanzania, triphasic abdominal Computed Tomography (CT) is a more accessible and non-invasive alternative for diagnosing esophageal varices, though its accuracy has not been thoroughly evaluated, therefore this study aimed to determine the diagnostic accuracy of triphasic abdominal CT in detecting esophageal varices using esophagogastroduodenoscopy (OGD) as the gold standard among patients with upper gastrointestinal bleeding at Muhimbili National Hospital (MNH). Methods: This cross-sectional study was conducted at MNH from January 2021 to May 2023. We sampled upper gastrointestinal bleeding patients who underwent both OGD and triphasic abdominal CT using non-probability consecutive sampling. The sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and accuracy of triphasic abdominal CT were assessed against OGD findings. Results: In a study of 200 participants, esophageal varices were detected in 54% by OGD and 53.5% by CT. We observed 105 true positives, 2 false positives, 90 true negatives, and 3 false negatives. Triphasic abdominal CT demonstrated a sensitivity of 97.2%, specificity of 97.8%, PPV of 98.1%, NPV of 96.8%, and an accuracy of 97.5%. Extraluminal findings included portal venous thrombosis in (22%), splenic collateral (51.5%), ascites (32%), hepatocellular carcinoma (13%), and periportal fibrosis (32%). Conclusion: Triphasic abdominal Computed Tomography can be used as a reliable and non-invasive alternative modality for diagnosing and screening esophageal varices in resource-limited settings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. 肝硬化食管胃静脉曲张患者门静脉血栓形成及内镜治疗后 门脉高压性胃病加重的危险因素分析.
- Author
-
高淑娟, 许邵娴, 崔仕元, 王 萍, and 刘贵生
- Subjects
- *
GASTRIC varices , *VARICOSE veins , *PORTAL vein , *PORTAL hypertension , *PATIENT portals , *ESOPHAGEAL varices - Abstract
Objective: To explore the risk factors of portal vein thrombosis and treatment of backdoor hypertension in patients with esophageal and gastric varices. Methods: In tively, 102 patients from January 2019, all patients underwent endoscopic treatment with oesophageal and gastric varices, with portal venous thrombosis group (n=48 cases) and non-portal vein thrombosis (54 cases),compared with the two groups of laboratory examination, general clinical data, imaging examination results, and multifactor Logistic regression analysis was used to determine the risk factors of esophageal and gastric venous thrombosis. According to whether the patient has portal hypertension gastric disease aggravation after treatment. 102 patients were divided into portal hypertension plus restructuring and no portal hypertension and aggravation, and the general data and laboratory examination results of the two groups were compared.Multivariate Logistic regression analysis identified the risk factors for endoscopic treatment of posterior artery hypertension gastric disease aggravation. Results: The proportion of endoscopic esophageal varicose portal vein thrombosis was 47.06% (48/102). Univariate analysis showed that splenectomy history of portal vein thrombosis, gastric sclerosis injection, PLT, FIB, D2, internal diameter of portal vein, spleen length, spleen thickness, and splenic vein diameter without portal vein thrombosis (P<0.05); multifactor Logistic regression analysis showed that the history of splenectomy, D-dimer, PLT, splenic thickness, and enlarged splenic vein diameter were the risk factors for portal vein thrombosis in patients with cirrhosis (P<0.05). The proportion of endoscopic treatment for backdoor hypertension gastric disease aggravation was 29.41% (30/102). The results of the univariate analysis showed that, Portal hypertensive gastric disease and esophageal gastric Pux grade, Child-Pugh grade, Hp infection, portal vein flow history, portal vein trunk diameter and splenic vein diameter (P<0.05); The multivariate Logistic regression analysis showed that, Severe esophageal varicose veins, Child-Pugh grade C, Hp infection, and history of portal vein disconnection were the risk factors for endoscopic treatment of posterior artery hypertension in cirrhosis (P<0.05). Conclusion: A history of splenectomy, D-dimer, PLT, splenic thickness, and elevated splenic vein diameter are the risk factors for portal vein thrombosis of esophageal and gastric varices, severe, Child-Pugh grade C, Hp infection, and a history of portal vein rupture are the risk factors for the aggravation of portal hypertensive gastric disease after endoscopic treatment of liver cirrhosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Liver Stiffness Measurement Using Transient Elastography as a Predictor of Esophageal Varices in Chronic Liver Disease: A Clinical Study.
- Author
-
Bansal, Dharam Prakash, Bharwad, Vikrambhai, Rijhwani, Puneet, and Rajender, Akash
- Subjects
- *
ESOPHAGEAL varices , *METABOLIC detoxification , *ASPARTATE aminotransferase , *LIVER diseases , *CHRONICALLY ill - Abstract
Introduction: Chronic liver disease (CLD) represents a progressive deterioration of liver functions over a period exceeding six months, encompassing synthesis of clotting factors, detoxification of metabolic byproducts, and bile excretion. Aim: To evaluate the association of transient elastography with endoscopic grading of esophageal varices (EVs) and to identify non-invasive predictors of EVs in patients with chronic liver disease (CLD). Methods: A total of 200 patients with CLD were enrolled in this study. Subjects underwent clinical examination, laboratory investigations, transient elastography, and endoscopy. Liver stiffness measurements obtained via transient elastography were correlated with the presence and grading of EVs. Additional non-invasive parameters, such as the Aspartate Aminotransferase/Platelet Ratio Index (APRI) and ultrasound findings, were also analyzed. Results: Out of 200 patients, 110 (55%) had esophageal varices. Patients with varices had significantly higher liver stiffness values (33.87±14.47 kPa) compared to those without varices (13.38±8.29 kPa) (p<0.01). The APRI values were significantly associated with the presence of varices (1.84±4.47 in patients with varices vs. 0.91±0.8 in patients without varices; p<0.01). No significant association was found between the presence of varices and gender (p=0.79). Conclusion: Transient elastography is a valuable non-invasive tool for predicting esophageal varices in patients with chronic liver disease. The use of non-invasive parameters such as APRI and liver elastography can effectively identify patients at risk for varices, reducing the need for invasive endoscopy and improving patient management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
27. A study of non-invasive predictors of esophageal varices in patients with cirrhosis of liver - A cross-sectional study.
- Author
-
Mujahid, Nauman, Aithal, Kiran, and M., Dhananjaya
- Subjects
- *
ESOPHAGEAL varices , *CIRRHOSIS of the liver , *MEDICAL sciences , *CROSS-sectional method , *MEDICAL screening , *PLATELET count - Abstract
Background: Current guidelines advise that patients diagnosed with liver cirrhosis undergo screening through upper gastrointestinal endoscopy to detect esophageal varices (EV). Prophylactic measures should be taken for those with large varices on diagnosis and during follow-up. However, this poses a dual challenge, both social and medical, as the number of cirrhotic patients rises while the availability of endoscopy units remains limited. Aims and Objectives: In this study, we aim to evaluate the diagnostic accuracy of the noninvasive predictors such as spleen size, platelet count (PC), and PC/spleen diameter (PC/ SD) ratio for the diagnosis of EV. Materials and Methods: This hospital-based prospective observational study was done in the SDM College of Medical Sciences and Hospital, Dharwad, among 50 patients with cirrhosis of liver. Results: Among the 50 patients studied males pre-dominated the study with 80%. Out of the study population, 70% of the patients had varices. For a cutoff point of PC/SD ratio 916, the sensitivity was 71.42% and specificity was 93.3%. For a cutoff value of PC of 1.32 lakhs, the sensitivity was 71.42%, and the specificity was 73.3%. For a cutoff value of the longest SD of 12.40 cm, the sensitivity was 94.30%, and specificity was 33.3%. Conclusion: These non-invasive predictors can be useful screening tools for the diagnosis of EV. These can be effective for the initiation of prophylactic treatment when the endoscopy facility is not available. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Clinical Analysis of Sinistral Portal Hypertension.
- Author
-
Jie Zheng, Gang Luo, and Ming Ming Den
- Subjects
- *
ACADEMIC medical centers , *ESOPHAGEAL varices , *PANCREATIC diseases , *PORTAL hypertension , *COMPUTED tomography , *SPLENIC vein , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *TREATMENT effectiveness , *LONGITUDINAL method , *CHRONIC diseases , *PANCREATITIS , *MEDICAL records , *ACQUISITION of data , *ENDOSCOPIC gastrointestinal surgery , *SPLENECTOMY , *COMPARATIVE studies , *DATA analysis software , *SPLEEN diseases , *CONTRAST media , *DISEASE complications , *SYMPTOMS - Abstract
Background: Sinistral portal hypertension (SPH) is the only type of portal hypertension that is entirely curable. However, it can easily cause varicose veins in the esophagus and/or stomach, as well as upper gastrointestinal hemorrhage. This study aimed to investigate the clinical characteristics and treatments of sinistral portal hypertension. Methods: All patients with pancreatic disease were included in this retrospective cohort study at the Affiliated Hospital of Southwest Medical University (Luzhou, China) from September 2019 to September 2021. The required information including the patient's demographics, serum laboratory indicators, imaging and endoscopy examinations, and clinical features were gathered and evaluated. The results were expressed as numbers and percentages. Results: Out of the 830 patients with pancreatic diseases, 61 (7.3%) developed SPH. The most common cause of SPH was acute pancreatitis (80.3%), followed by chronic pancreatitis (11.5%). The splenic vein was the most frequently affected vein in patients (45/61, 73.8%). The findings of the contrastenhanced computed tomography (CECT) indicated that 51 cases (83.6%) had gastric fundal-body varices, and three cases had combined gastric and esophageal varices. In the perigastric collateral channel formation, gastroepiploic varices (43/61, 70.5%) most frequently occurred in patients with SPH. Splenomegaly was a prevalent manifestation in SPH patients (45.9%). Five cases had gastrointestinal variceal hemorrhage. Conclusion: SPH was associated with the patency of the splenic vein and the formation of distinctive perigastric collateral veins. Surgery and/or endoscopic treatment were recommended, particularly for patients who have experienced a significant amount of gastrointestinal bleeding and have failed conservative treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Validation of a Machine Learning Algorithm, EVendo, for Predicting Esophageal Varices in Hepatocellular Carcinoma.
- Author
-
Yang, Jamie O., Chittajallu, Punya, Benhammou, Jihane N., Patel, Arpan, Pisegna, Joseph R., Tabibian, James, and Dong, Tien S.
- Subjects
- *
MACHINE learning , *ESOPHAGEAL varices , *MEDICAL care costs , *HEPATOCELLULAR carcinoma , *GASTROINTESTINAL hemorrhage - Abstract
Background: Treatment with atezolizumab and bevacizumab has become standard of care for advanced unresectable hepatocellular carcinoma (HCC) but carries an increased gastrointestinal bleeding risk. Therefore, patients are often required to undergo esophagogastroduodenoscopy (EGD) to rule out esophageal varices (EV) prior to initiating therapy, which can delay care and lead to unnecessary procedural risks and health care costs. In 2019, the EVendo score was created and validated as a noninvasive tool to accurately screen out patients who were at low risk for having EV that required treatment. We sought to validate whether the EVendo score could be used to accurately predict the presence of EV and varices needing treatment (VNT) in patients with HCC. Methods: This was a retrospective multicenter cohort study of patients with HCC from 9/2004 to 12/2021. We included patients who underwent EGDs within 1 year after their HCC diagnosis. We collected clinical parameters needed to calculate an EVendo score at the time of EGD and compared the EVendo model prediction to the gold standard endoscopic report in predicting presence of VNT. Results: 112 with HCC were recruited to this study, with 117 qualifying EGDs. VNT occurred in 39 (33.3%) patients. The EVendo score had a sensitivity of 97.4% and a negative predictive value of 96.9%, supporting the validity in applying EVendo in predicting VNT in HCC. Conclusion: In this study, we validated the use of the EVendo score in ruling out VNT in patients with HCC. The application of the EVendo score could safely defer about 30% of EGDs for EV screening in HCC patients. Although additional validation cohorts are needed, this suggests that EVendo score can potentially be applied in patients with HCC to avoid unnecessary EGDs, which can ultimately mitigate healthcare costs and delays in initiating HCC treatment with atezolizumab and bevacizumab. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Esophagogastroduodenoscopy findings that do no not explain dysphagia are associated with underutilization of high-resolution manometry.
- Author
-
Pomenti, Sydney, Nathanson, John, Phipps, Meaghan, Aneke-Nash, Chino, Katzka, David, Freedberg, Daniel, and Jodorkovsky, Daniela
- Subjects
- *
BARRETT'S esophagus , *ESOPHAGEAL varices , *EOSINOPHILIC esophagitis , *ESOPHAGOGASTRIC junction , *HIATAL hernia , *ESOPHAGEAL motility disorders - Abstract
In patients with dysphagia that is not explained by upper endoscopy, high-resolution esophageal manometry (HRM) is the next logical step in diagnostic testing. This study investigated predictors of failure to refer for HRM after an upper endoscopy that was performed for but did not explain dysphagia. This was a retrospective cohort study of patients >18 years of age who underwent esophagogastroduodenoscopy (EGD) for dysphagia from 2015 to 2021. Patients with EGD findings that explained dysphagia (e.g. esophageal mass, eosinophilic esophagitis, Schatzki ring, etc.) were excluded from the main analyses. The primary outcome was failure to refer for HRM within 1 year of the index non-diagnostic EGD. We also investigated delayed referral for HRM, defined as HRM performed after the median. Multivariable logistic regression modeling was used to identify risk factors that independently predicted failure to refer for HRM, conditioned on the providing endoscopist. Among 2132 patients who underwent EGD for dysphagia, 1240 (58.2%) did not have findings to explain dysphagia on the index EGD. Of these 1240 patients, 148 (11.9%) underwent HRM within 1 year of index EGD. Endoscopic findings (e.g. hiatal hernia, tortuous esophagus, Barrett's esophagus, surgically altered anatomy not involving the gastroesophageal junction, and esophageal varices) perceived to explain dysphagia were independently associated with failure to refer for HRM (adjusted odds ratio 0.45, 95% confidence interval 0.25–0.80). Of the 148 patients who underwent HRM within 1 year of index EGD, 29.7% were diagnosed with a disorder of esophagogastric junction outflow, 17.6% with a disorder of peristalsis, and 2.0% with both disorders of esophagogastric outflow and peristalsis. The diagnosis made by HRM was similar among those who had incidental EGD findings that were non-diagnostic for dysphagia compared with those who had completely normal EGD findings. Demographic factors including race/ethnicity, insurance type, and income were not associated with failure to refer for HRM or delayed HRM. Patients with dysphagia and endoscopic findings unrelated to dysphagia have a similar prevalence of esophageal motility disorders to those with normal endoscopic examinations, yet these patients are less likely to undergo HRM. Provider education is indicated to increase HRM referral in these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. The Role of CT-Angiography in the Acute Gastrointestinal Bleeding.
- Author
-
Bayoumi, Sameh Saber, Abo Alezz, Ahmed Osman, Abdlsed, Amna Almabrouk, and Ali, Reham Ramadan
- Subjects
- *
GASTRIC varices , *GASTROINTESTINAL hemorrhage , *ESOPHAGEAL varices , *COMPUTED tomography , *ARTERIOVENOUS malformation - Abstract
Background: CT angiography (CTA), a minimally invasive diagnostic technique, has become popular for looking into acute gastrointestinal hemorrhages. This study aimed to evaluate the validity of Computed tomography angiography (CTA) for diagnosis of the cause of acute GIB and its influence on treatment. Methods: This study was carried out in Radiodiagnosis Department, Faculty of Medicine, Zagazig University on 24 cases with acute GIB during the period from June 2023 to December 2023 on 24 patients who were acute GIB. Age > 18 years. Both male and female were included as a comprehensive sample. Results: The most frequent diagnoses detected by CT-angiography among patients were esophageal gastric varices which was detected among (75%) of the patients, while the least frequent diagnoses detected was pancreatic arteriovenous malformations in 25% of patients. There was no significant difference between bleeding type and age or gender (P>0.05). sensitivity of CT angiography in diagnoses bleeding compared to endoscopy is (92.3%), positive predictive value (PPV) is (63.2%), negative predictive value (NPV) is (80.0%), accuracy of Ct angiography in diagnoses bleeding compared to endoscopy is (66.7%). Conclusions: CT angiography is a valid, noninvasive method that is conveniently accessible. CT angiography has a high sensitivity in identifying the source of current bleeding. The results of CT angiography are useful in guiding the best course of treatment (directed endoscopic intervention, angiographic embolization, or surgery), as well as in determining when these treatments should be carried out [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Platelet count/spleen diameter ratio for the non-invasive diagnosis of esophageal varices in Iranian patients with cirrhosis
- Author
-
Seyed-Kazem Hosseini-Ghaziani, Afshin Shafaghi, Farahnaz Joukar, Negin Letafatkar, Arman Habibi, Saman Maroufizadeh, and Saba Fakhrieh Asl
- Subjects
platelet count ,spleen diameter ,platelet count/spleen diameter ratio ,hepatic cirrhosis ,esophageal varices ,Medicine - Abstract
Introduction: Esophageal varices (EVs) carry a significant risk of rupture and subsequent life-threatening bleeding. While previous research has investigated the effectiveness of the platelet count to spleen diameter ratio (PC/SD) as a non-invasive predictor of EVs in various populations, this study specifically focuses on the Iranian population to assess the applicability and effectiveness of this parameter in this region. Materials and Methods: Upper gastrointestinal endoscopy was performed on 147 cirrhotic patients to screen for EVs. Biochemical tests and ultrasonography were done to measure spleen diameter (SD) and calculate the PC/SD ratio. ROC analysis was done to determine the predictive performance of the parameters. Results: Among the patients, 73% had EVs. The analysis showed the following: platelet count (PC) had an AUC of 0.695 with 78.7% sensitivity and 56.4% specificity; SD had an AUC of 0.750 with 49.1% sensitivity and 89.7% specificity; and the PC/SD ratio had an AUC of 0.734 with 60.2% sensitivity and 79.5% specificity. The PC/SD ratio exhibited a high positive predictive value of 93% but a low negative predictive value of 41.9%. Optimal cutoff values were determined as follows: PC≤ 100,000, SD< 163, and PC/SD ratio≤ 523. Conclusion: By identifying high-risk patients who may benefit from targeted endoscopic screening, this non-invasive method could contribute to improving overall patient care and reducing the need for invasive procedures. However, due to suboptimal performance results, it is crucial to use this approach with caution, as endoscopic screening remains the standard practice for the diagnosis and management of esophageal varices.
- Published
- 2024
33. Predictive factors of portal hypertensive enteropathy exacerbations based on long-term outcomes
- Author
-
Yuka Matsubara, Akiyoshi Tsuboi, Issei Hirata, Akihiko Sumioka, Takeshi Takasago, Hidenori Tanaka, Ken Yamashita, Yuichi Hiyama, Hidehiko Takigawa, Eisuke Murakami, Masataka Tsuge, Yuji Urabe, and Shiro Oka
- Subjects
Esophageal varices ,Splenectomy ,Portal hypertension ,Gastrointestinal bleeding ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Abstract Background Portal hypertensive enteropathy (PHE) is a small-bowel lesion observed in patients with portal hypertension. The clinical significance of endoscopic findings in PHE remains unclear. We aimed to clarify the clinical significance and predictive factors of capsule endoscopic findings in patients with PHE based on long-term outcomes. Methods This retrospective study enrolled 55 patients with PHE (33 males and 22 females; median age, 64 years; range, 23–87) followed for > 3 years using capsule endoscopy (CE) between February 2009 and May 2023. We evaluated the clinical factors affecting PHE exacerbations and the effects of PHE exacerbations on gastrointestinal bleeding by comparing exacerbated and unchanged PHE groups. Results Overall, 3 (5%) patients showed improvement, 33 (60%) remained unchanged, and 19 (35%) showed exacerbation on follow-up CE. In the exacerbated group, the rates of worsened fibrosis-4 index, exacerbated esophageal varices, and exacerbated portal hypertensive gastropathy were significantly higher than those in the unchanged group (21%, 32%, and 42% vs. 3%, 6%, and 12%, respectively; P
- Published
- 2024
- Full Text
- View/download PDF
34. Clinical characteristics and management of patient with portal hypertension at tertial level hospital in Tanzania
- Author
-
Paul William Itule, Ally Mwanga, Ramadhani Hassani Khamisi, Moses Byomuganyizi, William Lutege, and Tryphone Buchard Kagaruki
- Subjects
Portal hypertension ,Esophageal varices ,Liver cirrhosis ,Liver transplant and Child pugh ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Background Portal hypertension is a common diagnosis in Sub-Saharan African countries, with the majority of patients presenting late. This study aimed to understand Clinical characteristics, aetiology, the treatment offered in our setting, and factors associated with portal hypertension at a tertiary-level hospital, in Tanzania. Methodology A prospective cross-sectional observational single hospital-based study was conducted at MNH, from May 2021 to April 2022. A minimum of 152 subjects were required with an error of less than 5% and a study power of 80% at a 95% confidence interval. A structured questionnaire was used to collect data. Ethical clearance was obtained from the MUHAS/MNH IRB. Results A total of 154 eligible participants consented and participated in this study. The mean age of participants was 42 ± 15.8 years (range 2–87). Most of the study participants were males 64.9% with a male-to-female (M: F) ratio of 1.8:1. Vomiting blood was the common symptom among the study participants 51.3%. Schistosomiasis 53.9% and viral infection 26.6% were the common etiologies followed by alcohol abuse 7.8%. Most were medically treated at 89.61% followed by radiological treatment at 8.44% while only 1.95% of patients received surgical treatment. There was a significant association between the grade of oesophagal varices and bleeding consequences (p-value
- Published
- 2024
- Full Text
- View/download PDF
35. The diagnostic accuracy of triphasic abdominal CT in detecting esophageal varices
- Author
-
Suzana Lukoo, Balowa Musa, Lilian Salingwa, Gerard Mpemba, and Ahmed Jusabani
- Subjects
Esophageal varices ,Triphasic abdominal CT ,Oesophagoduodenoscopy ,Medical technology ,R855-855.5 - Abstract
Abstract Background In Tanzania, triphasic abdominal Computed Tomography (CT) is a more accessible and non-invasive alternative for diagnosing esophageal varices, though its accuracy has not been thoroughly evaluated, therefore this study aimed to determine the diagnostic accuracy of triphasic abdominal CT in detecting esophageal varices using esophagogastroduodenoscopy (OGD) as the gold standard among patients with upper gastrointestinal bleeding at Muhimbili National Hospital (MNH). Methods This cross-sectional study was conducted at MNH from January 2021 to May 2023. We sampled upper gastrointestinal bleeding patients who underwent both OGD and triphasic abdominal CT using non-probability consecutive sampling. The sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and accuracy of triphasic abdominal CT were assessed against OGD findings. Results In a study of 200 participants, esophageal varices were detected in 54% by OGD and 53.5% by CT. We observed 105 true positives, 2 false positives, 90 true negatives, and 3 false negatives. Triphasic abdominal CT demonstrated a sensitivity of 97.2%, specificity of 97.8%, PPV of 98.1%, NPV of 96.8%, and an accuracy of 97.5%. Extraluminal findings included portal venous thrombosis in (22%), splenic collateral (51.5%), ascites (32%), hepatocellular carcinoma (13%), and periportal fibrosis (32%). Conclusion Triphasic abdominal Computed Tomography can be used as a reliable and non-invasive alternative modality for diagnosing and screening esophageal varices in resource-limited settings.
- Published
- 2024
- Full Text
- View/download PDF
36. A study of non-invasive predictors of esophageal varices in patients with cirrhosis of liver – A cross-sectional study
- Author
-
Nauman Mujahid, Kiran Aithal, and Dhananjaya M
- Subjects
esophageal varices ,thrombocytopenia ,hepatic cirrhosis ,gastrointestinal endoscopy ,Medicine - Abstract
Background: Current guidelines advise that patients diagnosed with liver cirrhosis undergo screening through upper gastrointestinal endoscopy to detect esophageal varices (EV). Prophylactic measures should be taken for those with large varices on diagnosis and during follow-up. However, this poses a dual challenge, both social and medical, as the number of cirrhotic patients rises while the availability of endoscopy units remains limited. Aims and Objectives: In this study, we aim to evaluate the diagnostic accuracy of the non-invasive predictors such as spleen size, platelet count (PC), and PC/spleen diameter (PC/SD) ratio for the diagnosis of EV. Materials and Methods: This hospital-based prospective observational study was done in the SDM College of Medical Sciences and Hospital, Dharwad, among 50 patients with cirrhosis of liver. Results: Among the 50 patients studied males pre-dominated the study with 80%. Out of the study population, 70% of the patients had varices. For a cutoff point of PC/SD ratio 916, the sensitivity was 71.42% and specificity was 93.3%. For a cutoff value of PC of 1.32 lakhs, the sensitivity was 71.42%, and the specificity was 73.3%. For a cutoff value of the longest SD of 12.40 cm, the sensitivity was 94.30%, and specificity was 33.3%. Conclusion: These non-invasive predictors can be useful screening tools for the diagnosis of EV. These can be effective for the initiation of prophylactic treatment when the endoscopy facility is not available.
- Published
- 2024
- Full Text
- View/download PDF
37. Liver function and portal‐systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices.
- Author
-
Hassanein, Tarek, Keaveny, Andrew P., Mantry, Parvez, Smith, Alastair D., McRae, Michael P., Kittelson, John, Helmke, Steve, Everson, Gregory T., Bambha, Kiran, Fuchs, Michael, Gilroy, Richard K., Reddy, K. Rajender, Shiffman, Mitchell L., Rahimi, Robert S., Hellstern, Paul A., Hill, John M., Kayali, Zeid, Denham, Doug, Qureshi, Kamran, and Smith, Brian
- Subjects
- *
ESOPHAGEAL varices , *ORAL drug administration , *LIVER diseases , *LIVER function tests , *GENERATING functions - Abstract
Summary: Background: The quantitative HepQuant SHUNT test of liver function and physiology generates a disease severity index (DSI) that correlates with risk for clinical complications, such as large oesophageal varices (LEVs). A derivative test, HepQuant DuO, generates an equivalent DSI and simplifies testing by requiring only oral administration of the test solution and two blood samples at 20 and 60 min. Aims: Since the DSIs measured from DuO and SHUNT are equivalent, we compared the diagnostic performance for large oesophageal varices (LEVs) between the DSIs measured from DuO and SHUNT tests. Methods: This study combined the data from two prospectively conducted US studies: HALT‐C and SHUNT‐V. A total of 455 subjects underwent both the SHUNT test and esophagogastroduodenoscopy (EGD). Results: DSI scores correlated with the probability of LEVs (p < 0.001) and demonstrated a stepwise increase from healthy lean controls without liver disease to subjects with chronic liver disease and no, small or large varices. Furthermore, a cutoff of DSI ≤ 18.3 from DuO had a sensitivity of 0.98 (missing only one case) and, if applied to the endoscopy (EGD) decision, would have prevented 188 EGDs (41.3%). The AUROC for DSI from DuO did not differ from that of the reference SHUNT test method (0.82 versus 0.81, p = 0.3500). Conclusions: DSI from HepQuant DuO links liver function and physiology to the risk of LEVs across a wide spectrum of patient characteristics, disease aetiologies and liver disease severity. DuO is minimally invasive, easy to administer, quantitative and may aid the decision to avoid or perform EGD for LEVs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Correction: Exploring the prognostic significance of blood carnitine and acylcarnitines in hepatitis C virus‑induced hepatocellular carcinoma.
- Author
-
Basuni, Ashraf Abbass, Sheashaey, Azza El, Fert, Ashraf El, Obada, Manar, Abdelsameea, Eman, Abdel‑Samiee, Mohamed, Ibrahim, Asmaa, and Khalil, Ashraf
- Subjects
- *
HEPATOCELLULAR carcinoma , *CARNITINE , *HEPATITIS , *ESOPHAGEAL varices , *CARNITINE palmitoyltransferase - Abstract
The document is a correction notice for an article published in the Egyptian Liver Journal. The corrections include changes to author names, references, and a table. The corrected article can be found online. The table in the document presents laboratory test results for patients with hepatocellular carcinoma (HCC) and hepatitis C virus (HCV) compared to a control group. The tests include ALT, AST, albumin, bilirubin, creatinine, AFP, Hb, WBC, PT%, and INR. The table provides statistical significance values for the differences between the groups. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
39. Visceral Fat Associated with Worsening of Recurrent Esophageal Varices in Alcoholic/Nonalcoholic Steatohepatitis-Related Liver Cirrhosis.
- Author
-
Ryohei Nishiguchi, Yoshihiro Furuichi, Takeshi Shimakawa, Shinichi Asaka, Kentaro Yamaguchi, Yukio Shimojima, Teppei Kono, Sachiyo Okayama, Rieko Shimojima, Masano Sagawa, Kotaro Kuhara, Takebumi Usui, Hajime Yokomizo, Seiji Ohigashi, Koichiro Sato, Hiroyuki Kato, and Shunichi Shiozawa
- Subjects
- *
HEPATITIS C , *HEPATIC fibrosis , *MEDICAL communication , *NON-alcoholic fatty liver disease , *NICOTINAMIDE adenine dinucleotide phosphate , *FATTY liver , *LIVER histology , *ESOPHAGEAL varices - Published
- 2024
- Full Text
- View/download PDF
40. Hand-assisted laparoscopic splenectomy and gastropancreatic fold division: a less-invasive simplified technique of Hassab's procedure for refractory esophagogastric varices.
- Author
-
Iwasaki, Hitoshi, Ninomiya, Mizuki, Itoh, Shinji, Takeishi, Kazuki, Higashi, Hidefumi, Iseda, Norifumi, Izumi, Takuma, Yoshiya, Shohei, Toshima, Takeo, and Yoshizumi, Tomoharu
- Subjects
- *
SPLENECTOMY , *ESOPHAGEAL varices , *PORTAL hypertension , *LAPAROSCOPIC surgery , *REFRACTORY materials , *TREATMENT effectiveness - Abstract
Some patients with refractory esophagogastric varices require surgery, such as gastric devascularization and splenectomy (Hassab's procedure). However, these patients are at risk of perioperative morbidities when undergoing devascularization to develop collateral vessels. We performed a more simplified procedure, splenectomy, and en bloc gastropancreatic fold division (GPFD) with hand-assisted laparoscopic surgery. Four patients with refractory esophagogastric varices and portal hypertension underwent splenectomy and GPFD. We reviewed patients' perioperative laboratory and morphological data, operative variables, and postoperative outcomes. Esophagogastric varices improved in 3 (75%) of the 4 patients. In one patient, esophageal varices (F1RC0) were observed 3 years after surgery, but they required no treatment and only received follow-up. Treatment with splenectomy and GPFD is not only less invasive than Hassab's procedure but also provides effective outcomes for refractory esophagogastric varices. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Incidence of cirrhosis in Iceland—impact of the TraP HepC nationwide HCV elimination program.
- Author
-
Haraldsson, Halldor A., Olafsson, Sigurdur, Gottfredsson, Magnus, Benitez Hernandez, Ubaldo, and Bjornsson, Einar S.
- Subjects
- *
ESOPHAGEAL varices , *CIRRHOSIS of the liver , *HEPATITIS C virus , *LIVER failure , *INTERNATIONAL normalized ratio , *HEPATITIS C - Abstract
In 2016, a nationwide elimination program for hepatitis C virus (HCV) was initiated in Iceland, entitled Treatment as Prevention for Hepatitis C (TraP HepC), providing unrestricted access to antiviral treatment. The aims were to describe the changes in etiology and epidemiology of cirrhosis in Iceland and to assess the trends in HCV-related cirrhosis following TraP HepC. The study included all patients newly diagnosed with cirrhosis in 2016–2022. Diagnosis was based on liver elastography, histology, or 2 of 4 criteria: cirrhosis on imaging, ascites, varices, or elevated international normalized ratio (INR). Over the study period, 342 new cirrhosis patients were identified, 223 (65%) males, median age 62 years. The crude overall incidence was 13.8 cases per 100,000 inhabitants annually. The most common etiologies were alcohol-related liver disease (ALD) (40%), metabolic dysfunction-associated steatotic liver disease (MASLD) (28%), and HCV with or without alcohol overconsumption (15%). The number of HCV cirrhosis cases was unusually high in 2016 (n = 23) due to intensified case-finding, but decreased significantly over the study period (p < 0.001) to n = 1 (2021) and n = 2 (2022). The overall 5-year survival was 55% (95% CI 48.9–62.3%). The most common causes of death were hepatocellular carcinoma (26%) and liver failure (25%). During the past two decades, the incidence of cirrhosis has increased extraordinarily in Iceland, associated with increased alcohol consumption, obesity, and HCV. ALD and MASLD now collectively make up two thirds of cases in Iceland. Following a nationwide elimination program, incidence of HCV cirrhosis has dropped rapidly in Iceland. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis.
- Author
-
Jung Yeon Joo, In Hyuk Yoo, and Hye Ran Yang
- Subjects
- *
HEPATIC fibrosis , *OVERWEIGHT children , *NON-alcoholic fatty liver disease , *ESOPHAGEAL varices , *BIOMARKERS , *ASPARTATE aminotransferase - Abstract
Purpose: The prevalence of nonalcoholic steatohepatitis (NASH) is increasing with the increasing prevalence of childhood obesity. Although NASH has a high risk of progression to liver fibrosis and cirrhosis, few studies have reported noninvasive markers for predicting hepatic fibrosis in children. This study aimed to evaluate and compare the diagnostic accuracies of serologic biomarkers and scoring systems for hepatic fibrosis in obese children with NASH. Methods: A total of 96 children were diagnosed with NASH based on liver biopsy findings and divided into two groups according to the degree of liver fibrosis: mild (stage 0-1) or advanced (stage 2-4). Clinical and laboratory parameters and serum levels of hyaluronic acid and type IV collagen were measured. The aspartate aminotransferase/platelet ratio index (APRI) and fibrosis-4 (FIB-4) score were calculated. Results: Among the noninvasive markers, only serum type IV collagen level and FIB-4 were significantly different between the two groups. The area under the receiver operating curve of each biomarker and scoring system was 0.80 (95% confidence interval [CI]: 0.70-0.90) for type IV collagen at an optimal cutoff of 148 ng/mL (sensitivity 69.8%, specificity 84.6%), followed by 0.69 (95% CI: 0.57-0.83) for APRI, 0.68 (95% CI: 0.56-0.80) for FIB-4, and 0.65 (95% CI: 0.53-0.77) for hyaluronic acid. Conclusion: Type IV collagen as a single noninvasive serologic biomarker for hepatic fibrosis and FIB-4 as a hepatic fibrosis score are beneficial in predicting advanced hepatic fibrosis and determining proper diagnosis and treatment strategies before fibrosis progresses in obese children with NASH. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Ascites affects the benefit of carvedilol on patients with liver cirrhosis and esophageal and gastric varices.
- Author
-
Xia, Ruiqi, Wu, Bing, Zhou, Ji, Ji, Mingyan, Wang, Shuyue, Zeng, Xiaoqing, and Chen, Shiyao
- Subjects
- *
GASTRIC varices , *ESOPHAGEAL varices , *CIRRHOSIS of the liver , *CARVEDILOL , *PATIENT portals , *H2 receptor antagonists , *PORTAL vein - Abstract
Esophageal and gastric varices (EGV) bleeding is a dangerous side effect of liver cirrhosis. Ascites may affect the effectiveness of carvedilol in preventing EGV rebleeding. A retrospective analysis was done on patients with EGV bleeding who visited our gastroenterology department between January 1, 2015, and October 29, 2020, and were given carvedilol therapy again. Patients were classified based on whether they had ascites. The primary outcome was EGV rebleeding. A total of 286 patients were included, with a median follow‐up of 24.0 (19.0–42.0) months, comprising those without ascites (N = 155) and those with ascites (N = 131). The mean age of the patients was 55.15 ± 12.44 years, and 177 (61.9%) of them were men. There were 162 (56.6%) Child‐Pugh A grades. The etiology of cirrhosis included 135 (47.2%) cases of hepatitis B. After carvedilol therapy, the patient's portal vein diameter (DPV) was widened (p < 0.05), velocity of portal vein (VPV) was slowed (p = 0.001). During the 1‐year follow‐up, patients with ascites had a substantially higher rebleeding rate than patients without ascites, with 24 (18.3%) versus 13 (8.4%), respectively (p = 0.013). On univariate analysis, ascites was a risk factor for rebleeding (p = 0.015). The multivariate analysis remained significant after adjusting for age, gender, etiology of cirrhosis, and previous endoscopic treatment, with OR of 2.37 (95% CI: 1.12–5.04; p = 0.025). Ascites was a risk factor for EGV rebleeding in patients undergoing carvedilol therapy. After carvedilol therapy, the patient's DPV was widened and VPV was slowed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Association of Omega-3 Polyunsaturated Fatty Acids with Sarcopenia in Liver Cirrhosis Patients with Hepatocellular Carcinoma.
- Author
-
Akitoshi Sano, Jun Inoue, Eiji Kakazu, Masashi Ninomiya, Mio Tsuruoka, Kosuke Sato, Masazumi Onuki, Satoko Sawahashi, Keishi Ouchi, and Atsushi Masamune
- Subjects
OMEGA-3 fatty acids ,MONOUNSATURATED fatty acids ,FATTY acid analysis ,EICOSAPENTAENOIC acid ,SATURATED fatty acids ,ESOPHAGEAL varices - Published
- 2024
- Full Text
- View/download PDF
45. Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry.
- Author
-
Elstein, Deborah, Belmatoug, Nadia, Bembi, Bruno, Deegan, Patrick, Fernandez-Sasso, Diego, Giraldo, Pilar, Göker-Alpan, Özlem, Hughes, Derralynn, Lau, Heather, Lukina, Elena, Revel-Vilk, Shoshana, Schwartz, Ida Vanessa D., Istaiti, Majdolen, Botha, Jaco, Gadir, Noga, Schenk, Jörn, and Zimran, Ari
- Subjects
- *
MEDICAL registries , *ENZYME replacement therapy , *GAUCHER'S disease , *GLOBAL method of teaching , *ESOPHAGEAL varices , *PLATELET count - Abstract
Background: Long-term patient registries are important for evaluating treatment outcomes in patients with rare diseases, and can provide insights into natural disease history and progression in real-world clinical practice. Initiated in 2010, the Gaucher Outcome Survey (GOS) is an ongoing, international, multicenter, observational registry (ClinicalTrials.gov Identifier: NCT03291223) for patients with a diagnosis of Gaucher disease (GD), irrespective of treatment type or status, with a primary objective to monitor safety and long-term effectiveness of velaglucerase alfa. Methods: Here, we evaluated the GOS population 12 years after the registry initiation. Results: As of 25 February 2023, 2084 patients enrolled in the GOS and 1643 received GD-specific treatment. Patients exhibited broad heterogeneity at baseline: age of diagnosis (0 to 85.3 years), hemoglobin concentrations (<80.0 g/L to >150 g/L), platelet counts (<50 × 109/L to >450 × 109/L), and liver and spleen volumes. Most patients treated with enzyme replacement therapy or substrate reduction therapy reported improvements in clinical parameters within 1 year of treatment initiation, maintained over the course of treatment up to 12 years, whereas untreated patients had baseline values closer to standard reference thresholds and showed stability over time. Conclusion: The 12-year data from the GOS confirm the impact of long-term treatment with GD-specific agents and offer insights into disease progression and outcomes in a real-world setting. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Case report: Echocardiographic and computed tomographic features of congenital bronchoesophageal artery hypertrophy and fistula in a dog.
- Author
-
Yewon Ji, Jinsu Kang, Suyoung Heo, Kichang Lee, and Hakyoung Yoon
- Subjects
PULMONARY artery ,BRACHIOCEPHALIC trunk ,THORACIC aorta ,ARTERIES ,ECHOCARDIOGRAPHY ,FISTULA ,BRONCHIAL fistula - Abstract
Introduction: Studies on aberrant bronchoesophageal arteries are limited. Herein, we report a case of a multi-origin systemic-to-pulmonary shunt with suspected bronchoesophageal artery hypertrophy and fistula in a dog. Case report: A 4-year-old castrated male beagle weighing 11 kg underwent routine medical screening. Physical examination revealed a right-sided continuous murmur of grades 1-2. Thoracic radiography revealed a mild cardiomegaly. Echocardiography revealed a continuous turbulent shunt flow distal to the right pulmonary artery (RPA) branch from the right parasternal short axis pulmonary artery view. Computed tomography demonstrated systemic-topulmonary shunts originating from the descending aorta at the level of T7-8, the right 5th and 6th dorsal intercostal arteries, and the right brachiocephalic trunk, which formed anomalous networks around the trachea and esophagus that anastomosed into a large tortuous vessel at the level of T6-7 and entered the RPA. Surgical ligation of multiple shunting vessels was performed. Postoperative echocardiography and computed tomography showed decreased left ventricular volume overload and markedly decreased size of the varices. Additionally, most of the shunting vessels were without residual shunt flow. Conclusion: The present study provides information regarding imaging features and the successful surgical management of multiple systemic-to-pulmonary shunts originating from the descending aorta, right brachiocephalic trunk, and intercostal arteries and terminating at the RPA. Multimodal imaging features after surgical ligation have also been described. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Portal vein thrombosis in patients with liver cirrhosis.
- Author
-
Savić, Željka, Damjanov, Dimitrije, Bošnjak, Olgica Latinović, Janjić, Nebojša, Dejanović, Božidar, Krnetić, Žarko, and Vračarić, Vladimir
- Subjects
- *
PORTAL vein , *CIRRHOSIS of the liver , *ESOPHAGEAL varices , *THROMBOSIS , *PORTAL hypertension - Abstract
Background/Aim. Portal vein thrombosis (PVT) in patients with liver cirrhosis (LC) has a prevalence of 0.6-26%. It is most commonly discovered incidentally as part of the evaluation of LC or in the context of acute decompensation of LC due to portal hypertension. The aim of the study was to determine the prevalence of PVT in patients with LC in relation to the severity of the disease and individual elements of portal hypertension. Methods. A total of 326 patients treated for LC decompensation were included in a retrospective study. Standard laboratory analyses, abdominal ultrasonography and/or computed tomography, and esophagogastroduodenoscopy were performed. Results. The diameter of the portal vein (PV) differed between patients without esophageal varices (12.2 mm) and those with large varices (13.6 mm), p = 0.026. PVT was identified in 6.1% of patients with LC. The patients were classified according to the Child-Pugh scoring system, which has the A, B, and C categories used to assess the severity of liver disease. PVT was present in 3.0% of patients in class C and 12.0% in class B, while none of the patients in class A had PVT (p = 0.005). PVT was present in 4.4% of patients with small varices and 16.7% with large varices (p < 0.001). There was no difference in the presence of PVT between the groups of patients with and without variceal bleeding nor between groups with different degrees of ascites. A fatal outcome occurred in 29.4% of patients, but there was no difference between patients with and without PVT. Conclusion. PVT is present in more advanced stages of LC and predominantly in patients with large esophageal varices. There was no higher prevalence of PVT observed with the occurrence of variceal bleeding or with the death outcome in patients with LC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.
- Author
-
Fujiwara, Kisako, Kondo, Takayuki, Fujimoto, Kentaro, Yumita, Sae, Ogawa, Keita, Ishino, Takamasa, Nakagawa, Miyuki, Iwanaga, Terunao, Tsuchiya, Satoshi, Koroki, Keisuke, Kanzaki, Hiroaki, Inoue, Masanori, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Ogasawara, Sadahisa, Nakamoto, Shingo, Chiba, Tetsuhiro, and Koizumi, Jun
- Subjects
- *
HEPATOCELLULAR carcinoma , *THERAPEUTIC complications , *DISEASE risk factors , *PORTAL hypertension , *ESOPHAGEAL varices , *COMPUTED tomography - Abstract
Background: During systemic therapy, the management of portal hypertension (PH)-related complications is vital. This study aimed to clarify factors associated with the incidence and exacerbation of PH-related complications, including the usefulness of contrast-enhanced computed tomography (CECT) in the management of PH-related complications during systemic therapy. Methods: A total of 669 patients who received systemic therapy as first-line treatment (443 patients for sorafenib, 131 for lenvatinib, and 90 for atezolizumab/bevacizumab [ATZ/BEV]) were enrolled in this retrospective study. Additionally, the lower esophageal intramural vessel diameters (EIV) on CECT and endoscopic findings in 358 patients were compared. Results: The cutoff values of the EIV diameter on CECT were 3.1 mm for small, 5.1 mm for medium, and 7.6 mm for large varices, demonstrating high concordance with the endoscopic findings. esophageal varices (EV) bleeding predictors include EIV ≥ 3.1 mm and portal vein tumor thrombosis (PVTT). In patients without EV before systemic therapy, factors associated with EV exacerbation after 3 months were EIV ≥ 1.9 mm and ATZ/BEV use. Predictors of hepatic encephalopathy (HE) include the ammonia level or portosystemic shunt diameter ≥ 6.8 mm. The incidence of HE within 2 weeks was significantly higher (18%) in patients with an ammonia level ≥ 73 μmol/L and a portosystemic shunt ≥ 6.8 mm. The exacerbating factors for ascites after 3 months were PVTT and low albumin levels. Conclusions: Careful management is warranted for patients with risk factors for exacerbation of PH-related complications; moreover, the effective use of CECT is clinically important. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Transjugular intrahepatic portosystemic shunt followed by splenectomy for complicated hepatosplenic schistosomiasis: a case report and review of the literature.
- Author
-
Tamarozzi, Francesca, Ursini, Tamara, Stroffolini, Giacomo, Badona Monteiro, Geraldo, Buonfrate, Dora, Fittipaldo, Veronica Andrea, Conci, Simone, Gasparini, Clizia, Mansueto, Giancarlo, Guglielmi, Alfredo, and Gobbi, Federico
- Subjects
- *
LITERATURE reviews , *SCHISTOSOMIASIS , *SPLENECTOMY , *PORTAL hypertension , *GASTROINTESTINAL hemorrhage , *ESOPHAGEAL varices - Abstract
Hepatosplenic schistosomiasis is a complex clinical condition caused by the complications of chronic infection with Schistosoma species that cause intestinal schistosomiasis. Hepatosplenic schistosomiasis derives from the fibrotic reaction stimulated around parasite eggs that are transported by the mesenteric circulation to the liver, causing periportal fibrosis. Portal hypertension and variceal gastrointestinal bleeding are major complications of hepatosplenic schistosomiasis. The clinical management of hepatosplenic schistosomiasis is not standardised and a parameter that could guide clinical decision making has not yet been identified. Transjugular intrahepatic portosystemic shunt (TIPS) appears promising for use in hepatosplenic schistosomiasis but is still reported in very few patients. In this Grand Round, we report one patient with hepatosplenic schistosomiasis treated with TIPS, which resulted in regression of oesophageal varices but had to be followed by splenectomy due to persisting severe splenomegaly and thrombocytopenia. We summarise the main challenges in the clinical management of this patient with hepatosplenic schistosomiasis, highlight results of a scoping review of the literature, and evaluate the use of of TIPS in patients with early hepatosplenic schistosomiasis, to improve the prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Is salvage Plug-Assisted Retrograde Transvenous Obliteration (PARTO) safe and effective for bleeding gastric varices ?- A preliminary single-center experience.
- Author
-
Patel, Ranjan Kumar, Tripathy, Taraprasad, Panigrahi, Manas Kumar, Nayak, Hemant Kumar, Samal, Subash Chandra, Pattnaik, Bramhadatta, Dutta, Tanmay, Gupta, Sunita, Mohakud, Sudipta, Naik, Suprava, and Deep, Nerbadyeswari
- Subjects
- *
GASTRIC varices , *SCLEROTHERAPY , *ESOPHAGEAL varices , *DERIVATIVES (Mathematics) , *PATIENT selection , *HEMORRHAGE - Abstract
Background: Vascular plug-assisted retrograde transvenous obliteration (PARTO) obliterates the gastric varices and portosystemic shunt, thus resulting in a lower rebleeding rate than endoscopic glue/sclerotherapy. Aims: To evaluate the safety and efficacy of PARTO as salvage therapy in liver cirrhosis with gastric variceal bleed (GVB) after failed endotherapy. We assessed the clinical success rate and changes in liver function at 6- months. Materials and methods: Patients who underwent salvage PARTO after failed endotherapy for GVB (between December 2021 and November 2022) were searched and analyzed from the hospital database. Clinical success rate and rebleed rate were obtained at six months. Child–Pugh score (CTP) and Model for end-stage liver disease (MELD) score were calculated and compared between baseline and 6-month follow-up. Results: Fourteen patients (n = 14, Child–Pugh class A/B) underwent salvage PARTO. Nine had GOV-2, and five had IGV-1 varices. The mean shunt diameter was 11.6 ± 1.6 mm. The clinical success rate of PARTO was 100% (no recurrent gastric variceal hemorrhage within six months). No significant deterioration in CTP (6.79 ± 0.98 vs. 6.21 ± 1.52; p = 0.12) and MELD scores (11.5 ± 4.05 vs. 10.21 ± 3.19; p = 0.36) was noted at 6 months. All patients were alive at 6 months. One patient (n = 1, 7.1%) bled from esophageal varices after three days of PARTO and was managed with variceal banding. 21.4% (3/14) patients had progression of esophageal varices at 6 months requiring prophylactic band ligation. Three patients (21.4%) had new onset or worsening ascites and responded to low-dose diuretics therapy. Conclusions: PARTO is a safe and effective procedure for bleeding gastric varices without any deterioration in liver function even after six months. Patient selection is critical to prevent complications. Further prospective studies with larger sample size are required to validate our findings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.